6 assets in Maligant Granulosa Cell Tumor Of Ovary

Therapeutic assets addressing Maligant Granulosa Cell Tumor Of Ovary, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Abemaciclib Maligant Granulosa Cell Tumor Of Ovary	Universitaire Ziekenhuizen KU Leuven	P2	CCC (53)
Darolutamide Maligant Granulosa Cell Tumor Of Ovary	National Cancer Institute (NCI)	P2	CCC (53)
Exemestane Maligant Granulosa Cell Tumor Of Ovary	National Cancer Institute (NCI)	P2	CCC (53)
Letrozole Maligant Granulosa Cell Tumor Of Ovary	Universitaire Ziekenhuizen KU Leuven	P2	CCC (53)
Leuporelin Maligant Granulosa Cell Tumor Of Ovary	National Cancer Institute (NCI)	P2	CCC (53)
Luspatercept Maligant Granulosa Cell Tumor Of Ovary	University Health Network, Toronto	N/A	D (30)